Holen Sie sich die Stockscreener-App
160.18
0.54%
-0.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$161.11
Offen:
$160.69
24-Stunden-Volumen:
524.68K
Relative Volume:
0.23
Marktkapitalisierung:
$38.21B
Einnahmen:
$222.29B
Nettoeinkommen (Verlust:
$1.56B
KGV:
24.99
EPS:
6.41
Netto-Cashflow:
$2.44B
1W Leistung:
-1.19%
1M Leistung:
-2.83%
6M Leistung:
+26.90%
1J Leistung:
+66.97%
1-Tages-Spanne:
$158.61
$160.97
1-Wochen-Bereich:
$158.61
$162.25
52-Wochen-Spanne:
$94.29
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Vergleichen Sie CAH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
160.08 | 39.21B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
710.43 | 90.83B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
295.15 | 58.18B | 310.23B | 1.69B | 3.58B | 8.62 |
|
HSIC
Henry Schein Inc
|
69.33 | 9.27B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.80 | 642.10M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health announces One Voice Initiative to support independent pharmacy advocacy - ETX View
Radiopharmaceuticals Market Top PlayersGE HealthCare, - openPR.com
Cardinal Health Surges to 331st in Daily Rankings with 3.09 Billion in Trading Volume - AInvest
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2025 on August 12 - The Malaysian Reserve
Cardinal Health: Navigating Growth and Dividends in a Challenging Healthcare Landscape - AInvest
Cardinal Health to Announce Fourth-Quarter and Year-End Results - GuruFocus
Cardinal Health Q4 Earnings Coming August 12: Full Year Results and Future Outlook Preview - Stock Titan
Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook - MSN
Should Value Investors Buy Cardinal Health (CAH) Stock? - Yahoo Finance
Cardinal Health's One Voice Initiative: A Strategic Play for Stakeholder Power and Shareholder Returns - AInvest
Cardinal Health (NYSE:CAH) Launches One Voice Initiative Supporting Independent Pharmacy Advocacy - simplywall.st
Cardinal Health Launches One Voice Initiative To Empower Pharmacy Advocacy - Nasdaq
Cardinal Health Launches One Voice Initiative to Bolster Independent Pharmacy Advocacy - AInvest
Cardinal Health announces One Voice Initiative to support indepe - GuruFocus
Cardinal Health Launches One Voice Initiative to Support Independent Pharmacy Advocacy - AInvest
Cardinal Health Launches One Voice Initiative for Pharmacy Advocacy - AInvest
Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries - GlobeNewswire Inc.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors - sharewise.com
Cardinal Health (NYSE:CAH) Targets Double-Digit EPS Growth Amid IRA Tailwinds and Healthcare Sector Strength - MSN
Cardinal Health survey reveals 25% of health systems use manual supply tracking; hospitals spent US$147B on medical supplies in 2023, up 4.7% from previous year - Industry Intelligence Inc.
Cardinal Health (CAH) Beat the Market in 2025 with Solid Healthcare Momentum - MSN
Cardinal Health ($CAH) Is Paying a $109M Settlement to Investors — Here’s How to Get Your Share - TradingView
Wound Care Centers Market Report 2025-2030, with Profiles of Smith & Nephew, 3M, Molnlycke Health Care, ConvaTec, Coloplast, Medline, Integra LifeSciences, B. Braun, Cardinal Health, & Derma Sciences - Yahoo Finance
Cardinal Health's (NYSE:CAH) investors will be pleased with their splendid 282% return over the last five years - simplywall.st
Cardinal Health (CAH) Surges Ahead: A Buy for Strong Earnings Momentum and Strategic Value - AInvest
Cardinal Health CEO tops pay rankings, AEP most profitable among Central Ohio public companies - The Business Journals
Cardinal Health Boosts Dividend and Gets Strong Analyst Ratings — What $CAH Investors Should Know - TradingView
Cardinal Health Could Beat Q2 Expectations — And Other News for $CAH Investors - TradingView
Cardinal Health Stock Climbs Ahead of Earnings — And Other News for $CAH Investors - TradingView
Cardinal Health (CAH) Laps the Stock Market: Here's Why - Yahoo Finance
Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy? - Nasdaq
JPMorgan Adjusts Price Target on Cardinal Health to $175 From $156 - MarketScreener
Cardinal Health (CAH) Soars 0.73% on Russell 1000 Index Inclusion - AInvest
Ex-Dividend Reminder: Agilent Technologies, Cardinal Health and Realty Income - Nasdaq
5 Must-Read Analyst Questions From Cardinal Health’s Q1 Earnings Call - Yahoo Finance
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks? - MSN
Cardinal Health stock hits all-time high at 166.3 USD - Investing.com
Cardinal Health, Inc. (CAH) CEO Is “Terrific,” Says Jim Cramer - Insider Monkey
Cardinal Health raises FY 2025 EPS guidance to $8.05-$8.15 amid strong pharma growth and acquisitions - MSN
Deutsche Bank Adjusts Cardinal Health Price Target to $163 From $148 - MarketScreener
Deutsche Bank Raises Price Target on Cardinal Health to $163 From $148, Keeps Hold Rating - marketscreener.com
Cardinal Health (NYSE:CAH) Eyes EPS Growth With IRA Momentum S&P 500 - Kalkine Media
Medical Commode Market Key Players Analysis -Medline - openPR.com
Cardinal Health raises FY25 earnings outlook on investor day - MSN
Cardinal Health Raises Pharmaceutical Segment Profit Guidance 12-13% for FY25 - cheddar.com
Jefferies Adjusts Price Target on Cardinal Health to $190 From $170, Maintains Buy Rating - marketscreener.com
12 Best Healthcare Stocks to Buy Now - Insider Monkey
TD Cowen Affirms Buy Rating on Cardinal Health - Yahoo Finance
Cardinal Health (CAH) Sees Increased Price Target to $182 by Argus | CAH Stock News - GuruFocus
Cardinal Health price target raised to $185 from $170 at UBS - Investing.com
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Finance
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
1.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):